Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00205075 · ClinicalTrials.gov registry record
Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 47
- Enrollment target
NCT00205075: Completed study, sponsored by University of Wisconsin, Madison.
NCT00205075 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00205075 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2004-08 |
| Est. Completion | 2008-06 |
What the finished NCT00205075 record still lists
NCT00205075 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00205075 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00205075 about?
NCT00205075 is a clinical study titled "Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression". The purpose of this study is to determine the effect of moderate alcohol intake on liver disease caused by HCV in terms of speed of progression as compared to those not drinking alcohol.
What is the current status of trial NCT00205075?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2004-08. Estimated completion is 2008-06.
Who is sponsoring clinical trial NCT00205075?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia